Company Filing History:
Years Active: 2010-2012
Title: The Innovative Contributions of Karin Conde-Knape
Introduction
Karin Conde-Knape is a notable inventor based in Englewood, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of neuropeptide-2 receptor agonists. With a total of 2 patents to her name, her work has the potential to impact the treatment of various diseases.
Latest Patents
Karin's latest patents focus on neuropeptide-2 receptor (Y-2R) agonists and their uses. These patents describe compounds that are useful for treating conditions such as obesity and diabetes. The compounds are characterized by a specific formula, including pharmaceutically acceptable salts, derivatives, and fragments. One of the key components in her research is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa), which plays a crucial role in the efficacy of these compounds.
Career Highlights
Throughout her career, Karin has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop her expertise and contribute to groundbreaking research in her field.
Collaborations
Karin has collaborated with esteemed colleagues such as Waleed Danho and George Kenneth Ehrlich. These partnerships have further enriched her research and innovation efforts.
Conclusion
Karin Conde-Knape's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.